Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure.
about
Camptothecin attenuates cytochrome P450 3A4 induction by blocking the activation of human pregnane X receptorCombination metronomic oral topotecan and pazopanib: a pharmacokinetic study in patients with gynecological cancer.Topotecan in the management of cervical cancer.Clinical pharmacology of camptothecins.
P2860
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
Pharmacokinetics and pharmacod ...... a limited-sampling procedure.
@ast
Pharmacokinetics and pharmacod ...... a limited-sampling procedure.
@en
type
label
Pharmacokinetics and pharmacod ...... a limited-sampling procedure.
@ast
Pharmacokinetics and pharmacod ...... a limited-sampling procedure.
@en
prefLabel
Pharmacokinetics and pharmacod ...... a limited-sampling procedure.
@ast
Pharmacokinetics and pharmacod ...... a limited-sampling procedure.
@en
P2093
P356
P1476
Pharmacokinetics and pharmacod ...... a limited-sampling procedure.
@en
P2093
Beijnen JH
Creemers GJ
Rodenhuis S
Schellens JH
de Boer-Dennert M
ten Bokkel Huinink WW
P2888
P304
P356
10.1007/S002800050479
P577
1996-01-01T00:00:00Z
P5875
P6179
1025856734